Transcription Cofactors of the Thyroid Hormone Receptor

甲状腺激素受体的转录辅因子

基本信息

项目摘要

DESCRIPTION (provided by applicant): The TRAP/Mediator complex contains at least 18 different subunits and plays an essential role in transcriptional activation by nuclear hormone receptors (NRs) as well as a broad range of other activators. A single subunit, TRAP220, acts as a pivotal signaling mediator of cellular growth and development in that it targets TRAP/Mediator to NRs and to the GATA family of transcription factors. TRAP220 is also thought to play an important structural role in terms of holocomplex assembly and stability, and may further act as a binding surface for other essential coregulatory factors. Accordingly, TRAP220 ablation in mice is embryonic lethal. We recently found that TRAP220 is inducibly phosphorylated in vivo and suspect that its functional activity is regulated by such events. We further hypothesize that TRAP220 contains as of yet uncharacterized regulatory domains critical for its coactivator function. The long-term objectives of this proposal are to clearly understand how TRAP220 becomes phosphorylated and how phosphorylation regulates TRAP220 activity in vivo. Furthermore, we seek to more precisely delineate TRAP220's intrinsic functional domains in terms of holocomplex assembly and transcriptional activation. Our specific goals are: 1) To identify the mechanism(s) of TRAP220 phosphorylation in vivo and to determine the precise location of TRAP220 phosphorylation sites. Specific TRAP220 PO4-sites and relevant kinases will be determined using electromobility shift assays, 32-po4-incorporation studies, and mass spectrometry. The specific PO4-sites and relevant kinases will be confirmed via mutagenesis and in vitro kinase reactions. 2) To investigate the functional consequences of TRAP220 phosphorylation. TRAP220 PO4-site mutants (per aim 1) will be tested for defective NR-binding, transcriptional coactivation, subcellular localization and colocalization with other cofactors. We will also carry out cell synchronization studies to examine whether TRAP220 displays cell cycle-dependent phosphorylation. 3) To define the structural elements of TRAP220 necessary for holocomplex assembly and coactivator function. TRAP220 deletion and site-directed mutants will be tested for loss of coactivation by transient transfection in cultured cells and by in vitro transcription assays with chromatin templates. Stably expressed TRAP220 deletion mutants will also be used to biochemically identify specific TRAP220-associated TRAP/Mediator subunits. Given the global importance of TRAP/Mediator, not only for NR signaling but also for transactivation by other regulatory factors, the studies here should have important implications for the transcription field in general. Significantly, these studies may also help to identify and define new targets for therapeutic agents in the treatment of hormone-dependent cancers.
描述(由申请人提供):TRAP/Mediator复合物包含至少18个不同的亚基,在核激素受体(nr)和其他多种激活剂的转录激活中起重要作用。单个亚基TRAP220作为细胞生长和发育的关键信号介质,它将TRAP/ mediator靶向于NRs和GATA转录因子家族。TRAP220也被认为在整体复合物的组装和稳定性方面起着重要的结构作用,并可能进一步作为其他必要的协同调节因子的结合表面。因此,小鼠的TRAP220消融是胚胎致死的。我们最近发现TRAP220在体内被诱导磷酸化,并怀疑其功能活性受到这些事件的调节。我们进一步假设TRAP220包含对其辅激活子功能至关重要的尚未表征的调控结构域。本提案的长期目标是清楚地了解TRAP220如何被磷酸化以及磷酸化如何调节TRAP220在体内的活性。此外,我们试图更精确地描述TRAP220在全复合体组装和转录激活方面的内在功能域。我们的具体目标是:1)确定TRAP220在体内磷酸化的机制,确定TRAP220磷酸化位点的精确位置。具体的TRAP220 po4位点和相关激酶将通过电迁移位移测定、32-po4结合研究和质谱测定来确定。具体的po4位点和相关的激酶将通过诱变和体外激酶反应来确定。2)研究TRAP220磷酸化的功能后果。将测试TRAP220 po4位点突变体(详见目标1)是否有缺陷的nr结合、转录共激活、亚细胞定位以及与其他辅因子的共定位。我们还将进行细胞同步研究,以检查TRAP220是否显示细胞周期依赖性磷酸化。3)定义完整复合物组装和辅激活子功能所需的TRAP220结构元素。TRAP220缺失和位点定向突变体将通过在培养细胞中瞬时转染和用染色质模板进行体外转录测定来检测共激活的丧失。稳定表达的TRAP220缺失突变体也将用于生化鉴定特定的TRAP220相关TRAP/Mediator亚基。鉴于TRAP/Mediator在全球范围内的重要性,不仅对NR信号传导,而且对其他调控因子的反激活也具有重要意义,因此本文的研究应该对转录领域具有重要意义。值得注意的是,这些研究也可能有助于确定和确定激素依赖性癌症治疗药物的新靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH D FONDELL其他文献

JOSEPH D FONDELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH D FONDELL', 18)}}的其他基金

Androgen Receptor Coregulators in Prostate Cancer
前列腺癌中的雄激素受体共调节因子
  • 批准号:
    6654934
  • 财政年份:
    2001
  • 资助金额:
    $ 28.02万
  • 项目类别:
Androgen Receptor Coregulators in Prostate Cancer
前列腺癌中的雄激素受体共调节因子
  • 批准号:
    6778267
  • 财政年份:
    2001
  • 资助金额:
    $ 28.02万
  • 项目类别:
Androgen Receptor Coregulators in Prostate Cancer
前列腺癌中的雄激素受体共调节因子
  • 批准号:
    6440964
  • 财政年份:
    2001
  • 资助金额:
    $ 28.02万
  • 项目类别:
Androgen Receptor Coregulators in Prostate Cancer
前列腺癌中的雄激素受体共调节因子
  • 批准号:
    6644087
  • 财政年份:
    2001
  • 资助金额:
    $ 28.02万
  • 项目类别:
Androgen Receptor Coregulators in Prostate Cancer
前列腺癌中的雄激素受体共调节因子
  • 批准号:
    6524662
  • 财政年份:
    2001
  • 资助金额:
    $ 28.02万
  • 项目类别:
TRANSCRIPTION COFACTORS OF THE THYROID HORMONE RECEPTOR
甲状腺激素受体的转录辅助因子
  • 批准号:
    6342519
  • 财政年份:
    1999
  • 资助金额:
    $ 28.02万
  • 项目类别:
TRANSCRIPTION COFACTORS OF THE THYROID HORMONE RECEPTOR
甲状腺激素受体的转录辅助因子
  • 批准号:
    2761258
  • 财政年份:
    1999
  • 资助金额:
    $ 28.02万
  • 项目类别:
Transcription Cofactors of the Thyroid Hormone Receptor
甲状腺激素受体的转录辅因子
  • 批准号:
    7195805
  • 财政年份:
    1999
  • 资助金额:
    $ 28.02万
  • 项目类别:
Transcription Cofactors of the Thyroid Hormone Receptor
甲状腺激素受体的转录辅因子
  • 批准号:
    6894647
  • 财政年份:
    1999
  • 资助金额:
    $ 28.02万
  • 项目类别:
Transcription Cofactors of the Thyroid Hormone Receptor
甲状腺激素受体的转录辅因子
  • 批准号:
    6826035
  • 财政年份:
    1999
  • 资助金额:
    $ 28.02万
  • 项目类别:

相似海外基金

Nitrosative stress and NO detoxifying reaction mechanisms in microbial nonheme diiron proteins
微生物非血红素二铁蛋白的亚硝化应激和NO解毒反应机制
  • 批准号:
    10656107
  • 财政年份:
    2023
  • 资助金额:
    $ 28.02万
  • 项目类别:
Arginyl-tRNA beyond translation: mechanism and regulation of protein arginylation
超越翻译的精氨酰-tRNA:蛋白质精氨酰化的机制和调控
  • 批准号:
    10711167
  • 财政年份:
    2023
  • 资助金额:
    $ 28.02万
  • 项目类别:
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
  • 批准号:
    10759950
  • 财政年份:
    2023
  • 资助金额:
    $ 28.02万
  • 项目类别:
SMC1A/3 cohesin complex-mediated silencing of unintegrated HIV-1 DNA and the antagonism by Vpr
SMC1A/3粘连蛋白复合物介导的未整合HIV-1 DNA的沉默和Vpr的拮抗作用
  • 批准号:
    10760648
  • 财政年份:
    2023
  • 资助金额:
    $ 28.02万
  • 项目类别:
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer
使用 Sepiaptein 使精氨酸代谢正常化以实现 HER2 乳腺癌的免疫刺激转变
  • 批准号:
    10776256
  • 财政年份:
    2023
  • 资助金额:
    $ 28.02万
  • 项目类别:
Regulation of erythroid iron metabolism by the CLPX unfoldase
CLPX 解折叠酶对红细胞铁代谢的调节
  • 批准号:
    10716494
  • 财政年份:
    2023
  • 资助金额:
    $ 28.02万
  • 项目类别:
Cystathionine Gamma Lyase (CSE) and Hydrogen Sulfide Regulation of Vascular Aging
胱硫醚γ裂解酶 (CSE) 和硫化氢对血管老化的调节
  • 批准号:
    10715408
  • 财政年份:
    2023
  • 资助金额:
    $ 28.02万
  • 项目类别:
ETS1-dependent combinatorial control of oncogenic transcription in Notch-activated T-ALL
Notch激活的T-ALL中致癌转录的ETS1依赖性组合控制
  • 批准号:
    10733945
  • 财政年份:
    2023
  • 资助金额:
    $ 28.02万
  • 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
  • 批准号:
    10723833
  • 财政年份:
    2023
  • 资助金额:
    $ 28.02万
  • 项目类别:
+TIPs as novel host capsid-binding co-factors in early HIV-1 infection
TIP 作为早期 HIV-1 感染中新型宿主衣壳结合辅助因子
  • 批准号:
    10709142
  • 财政年份:
    2023
  • 资助金额:
    $ 28.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了